Organization · Other
Nordstein AG
Nordstein AG is a Zurich-based financial services firm specializing in private equity investment brokerage and corporate finance consulting. It connects investors with companies seeking capital, particularly in the life sciences and healthcare sectors.
Overview
What Nordstein AG does
What Nordstein AG is
Nordstein AG is a Zurich-based financial services firm specializing in private equity investment brokerage and corporate finance consulting. It connects investors with companies seeking capital, particularly in the life sciences and healthcare sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Nordstein AG elsewhere
Open the official website or a supported primary organization account.
Capability profile
Nordstein AG as a funder
Investment thesis
Nordstein AG believes that direct private equity and venture capital participations can support Swiss innovation while providing investors access to attractive non-listed growth companies, particularly in biotech, pharma, and medtech sectors.
Focus narrative
Nordstein AG focuses on private equity investments, particularly in the medical technology, biotechnology, and pharmaceutical sectors. The firm provides advisory services that include assessing investment opportunities and risks, ensuring compliance with corporate governance standards, and facilitating fundraising for Swiss companies in growth-oriented sectors.
Value beyond capital
Nordstein AG adds value to its portfolio companies by providing access to capital, advisory services on investment opportunities, and ensuring compliance with corporate governance standards. The firm acts as a broker, connecting promising companies with investors while assessing risks and opportunities.
Focus and fit
- Stages
- Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · Diagnostics
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Resistell AG: Developed the world's fastest Antibiotic Susceptibility Testing (AST) platform, significantly reducing diagnostic time. Splint Invest: A platform democratizing access to alternative investments in assets like art and collectibles. Securecell AG: A life science company providing innovative solutions for bioprocesses and medical technology. TOPADUR Pharma AG: Focuses on developing medicines that improve quality of life, particularly in wound healing and vision preservation. Exploris Health AG: Offers an AI-based test for early detection of coronary heart disease, validated through clinical trials. Whitecell Power AG: Develops emission-neutral drive systems for transportation, focusing on sustainability. CUTISS AG: Provides personalized skin tissue therapy for patients with severe skin defects.
Common questions
What to know about Nordstein AG
Upseed classifies Nordstein AG under the Other organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.